The store will not work correctly when cookies are disabled.
2-(2,3-Dioxo-2,3-dihydro-indol-1-yl)-acetamide
ID: ALA79466
Cas Number: 85124-17-0
PubChem CID: 1906162
Max Phase: Preclinical
Molecular Formula: C10H8N2O3
Molecular Weight: 204.19
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)CN1C(=O)C(=O)c2ccccc21
Standard InChI: InChI=1S/C10H8N2O3/c11-8(13)5-12-7-4-2-1-3-6(7)9(14)10(12)15/h1-4H,5H2,(H2,11,13)
Standard InChI Key: PFDMWGKCXRICRV-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
5.0917 -8.0792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5750 -7.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -6.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3000 -7.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3042 -7.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3500 -8.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4000 -7.4042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3292 -5.9542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6417 -8.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5500 -9.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5792 -6.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5792 -8.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8667 -7.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8667 -7.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 1 1 0
6 1 1 0
7 6 1 0
8 2 2 0
9 3 2 0
10 7 2 0
11 7 1 0
12 4 2 0
13 5 2 0
14 15 2 0
15 13 1 0
3 4 1 0
12 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 204.19 | Molecular Weight (Monoisotopic): 204.0535 | AlogP: -0.30 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.47 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -0.51 | CX LogD: -0.51 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.67 | Np Likeness Score: -1.01 |
References
1. Shuttleworth SJ, Nasturica D, Gervais C, Siddiqui MA, Rando RF, Lee N.. (2000) Parallel synthesis of isatin-based serine protease inhibitors., 10 (22): [PMID:11086715] [10.1016/s0960-894x(00)00523-0] |
2. Hyatt JL, Moak T, Hatfield MJ, Tsurkan L, Edwards CC, Wierdl M, Danks MK, Wadkins RM, Potter PM.. (2007) Selective inhibition of carboxylesterases by isatins, indole-2,3-diones., 50 (8): [PMID:17378546] [10.1021/jm061471k] |